The company said Nirmatrelvir and Ritonavir tablets will soon be available in a combi-pack, sold under the brand name Paxzen, as a treatmen...

The company said that Nirmatrelvir and Ritonavir tablets in a combi pack as a treatment option for patients with mild to moderate symptoms ...

These include Cipla, Sun Pharma, Laurus Labs, Divi's Laboratories, Glenmark, Emcure, Macleods, SMS Pharmaceuticals, Strides, Torrent, Cadil...

The licences are applicable for both active pharmaceutical ingredients (API) and finished product in capsules form. It enables the company ...

Under the terms of the agreement, MPP will be permitted to further license non-exclusive sub-licences to manufacturers and diversify the ma...

MSD entered into a voluntary licensing agreement with five Indian drug makers including Sun Pharma, Cipla, Dr. Reddy’s, Emcure and Hetero f...

The Medicines Patent Pool is a United Nations-backed public health organisation that helps middle- and low-income countries get access to c...

The agreement sub-licenses Zydus to produce and sell daclatasvir in 112 low and middle income countries, it added.

Between 130 and 150 million people worldwide are estimated to have HCV. The vast majority lives in low and middle income countries, it adde...

Daclatasvir, discovered and developed by Bristol-Myer Squibb, is the first-in-class NS5A inhibitor used in combination with Sofosbuvir to t...

Aurobindo Pharma Chief Executive Officer said the new licence would help ensure the timely introduction of generic ATV in developing countr...

Shilpa Medicare inked an agreement with Gilead Sciences to increase access to medicines used for treatment of HIV/AIDS.

CCI has rejected a complaint against Gilead Sciences Inc that alleged the US-based pharmaceutical company of abusing its dominant position.

Hyderabad based Hetero labs through an agreement with Geneva based Medicines Patent Pool will produce four key HIV drugs developed by Gilea...

An independent mechanism that protects the patent rights of Big Pharma while allowing generic firms to sell cheap, copycat HIV drugs to poo...

Ranbaxy Laboratories, Matrix Laboratories, Hetero Drugs and Strides Arcolab can make and sell the three drugs in 100 countries by paying ro...

Indian drug makers and research cos can join 'patent pool' programme to develope low cost drugs for 16 neglected tropical diseases.